The InterX Lab Division is applying computational and structural techniques to understanding critical biological problems. Through understanding, we will gain insight and control over these processes. Our current focus is on developing new therapies for combating cancer; this leverages our in-depth knowledge of transcriptional regulation with the novel computational and structural methods we are developing.  

meet our lab team

InterX lab division

    Through the discovery of Buchner, Biology was relieved of another fragment of mysticism. The splitting up of sugar into CO2 and alcohol is no more the effect of a 'vital principle' than the splitting up of cane sugar by invertase. The history of this problem is instructive, as it warns us against considering problems as beyond our reach because they have not yet found their solution.

— Jacques Loeb


meet the team


David A. Bushnell, Ph.D.

  • linkedin_circleicon

Chief Scientific Officer – Labs Division


Michael D. Feese, Ph.D.

  • linkedin_circleicon

Senior Scientist; Director of Chemical Biology


Andrey Feklistov, Ph.D.

  • linkedin_circleicon

Scientific Director,

Head of Biology


Pierre-Jean Matteï, Ph.D.

  • linkedin_circleicon

Senior Scientist; Director of Structural Biology

Get in Touch! 



Share the amazing things customers are saying about your business. Double click, or click Edit Text to make it yours.


We are looking for exceptional individuals who want to be a part of cutting-edge physics and biophysics lab.

contact us!

InterX, Inc. Lab Division
3475 Edison Way, Suite O
Menlo Park, CA 94025

 (650) 293-0925